Beam Therapeutics Reports Pipeline Updates and First Quarter 2023 Financial Results
Focused on Executing Three Strategic Pillars – Hematology, Immunology/Oncology and Genetic Diseases – Potential for Long-Term Pipeline Growth and Sustained Impact on Patient Lives ... | May 10, 2023
Source: marketscreener.com